197
Views
54
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions

, , , , , , & , Ph.D. show all
Pages 948-954 | Received 22 Aug 2007, Accepted 07 Jan 2008, Published online: 01 Jul 2009

References

  • The American Cancer Society. Available at: http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_non-Hodgkins_lymphoma_32.asp. Accessed May 20, 2007.
  • Cuvillier O, Pirianov G, Kleuser B, Vanek P G, Coso O A, Gutkind S, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phospate. Nature (Lond) 1996; 381: 800–803
  • Maceyka M, Payne S G, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochem Biophys Acta 2002; 1585: 193–201
  • Macchia M, Barontini S, Bertini S, Di Bussolo V, Fogli S, Giovannetti E, et al. Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues. J Med Chem 2001; 44: 3994–4000
  • Cuvillier O. Sphingosine kinase-1 – a potential therapeutic target in cancer. Anticancer Drugs 2007; 18: 105–110
  • French K J, Schrecengost R S, Lee B D, Zhuang Y, Smith S N, Eberly J L, et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003; 63: 5962–5969
  • Bektas M, Jolly P S, Müller C, Eberle J, Spiegel S, Geilen C C. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 2005; 24: 178–187
  • Johnson K R, Johnson K Y, Crellin H G, Ogretmen B, Boylan A M, Harley R A, et al. Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J Histochem Cytochem 2005; 53: 1159–1166
  • Kawamori T, Osta W, Johnson K R, Pettus B J, Bielawski J, Tanaka T, et al. Sphingosine kinase 1 is up-regulated in colon carcinogenesis. Faseb J 2005
  • Le Scolan E, Pchejetski D, Banno Y, Denis N, Mayeux P, Vainchenker W, et al. Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood 2005; 106: 1808–1816
  • Sobue S, Iwasaki T, Sugisaki C, Nagata K, Kikuchi R, Murakami M, et al. Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes. Leukemia 2006; 20: 2042–2046
  • Van Brocklyn J R, Jackson C A, Pearl D K, Kotur M S, Snyder P J, Prior T W. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 2005; 64: 695–705
  • Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T, et al. Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 2005; 20: 1–8
  • Jaffe E S, Harris N L, Stein H, Vardiman J W. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001
  • Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(t)) method. Methods 2001; 25: 402–408
  • Francy J M, Nag A, Conroy E J, Hengst J A, Yun J K. Sphingosine kinase 1 expression is regulated by signaling through PI3K, AKT2, and mTOR in human coronary artery smooth muscle cells. Biochim Biophys Acta 2007; 1769: 253–265
  • Melendez A J, Carlos-Dias E, Gosink M, Allen J M, Takacs L. Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 2000; 251: 19–26
  • Pitson S M, D'andrea R J, Vandeleur L, Moretti P A, Xia P, Gamble J R, et al. Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. Biochem J 2000; 350: 429–441
  • Maceyka M, Sankala H, Hait N C, Le Stunff H, Liu H, Toman R, et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 2005; 280: 37118–37129
  • Xia P, Gamble J R, Wang L, Pitson S M, Moretti P A, Wattenberg B W, et al. An oncogenic role of sphingosine kinase. Curr Biol 2000; 10: 1527–1530
  • Pchejetski D, Golzio M, Bonhoure E, Calvet C, Doumerc N, Garcia V, et al. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 2005; 65: 11667–11675
  • Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat. 2007 Dec 4; [Epub ahead of print]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.